AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Earnings Release Jul 23, 2020

6219_rns_2020-07-23_3271d569-8e20-49ce-bf65-864c6b860e00.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 23 July 2020 18:42

SHOP APOTHEKE EUROPE raises full year 2020 guidance.

SHOP APOTHEKE EUROPE N.V. / Key word(s): Change in Forecast/Forecast

SHOP APOTHEKE EUROPE raises full year 2020 guidance.

23-Jul-2020 / 18:42 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


SHOP APOTHEKE EUROPE raises full year 2020 guidance.

According to preliminary calculations, SHOP APOTHEKE EUROPE has significantly improved its key earnings figures in the second quarter of 2020 in line with the increased business volume. Based on the developments in the first and second quarters and against the background of an overall slightly improved visibility for the remaining part of the year, SHOP APOTHEKE EUROPE is lifting its guidance for the 2020 financial year.

For the full year, the Management Board now expects a sales growth of at least 30% compared to the financial year 2019 (previously: at least 20%) and a positive adjusted EBITDA margin in the range of 1-2% (previously: a positive adjusted EBITDA).

SHOP APOTHEKE EUROPE will publish the full report for the first half of 2020 on August 6, 2020.

Contact:

rikutis consulting

Thomas Schnorrenberg

Cel: +49 151 46 53 13 17

E-Mail: [email protected]


23-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 – 200 800 300
Fax: 0800 – 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1100793
End of Announcement DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.